发明名称 PURIFICATION OF PERTUSSIS TOXIN
摘要 <p>Lymphocytosis promoting factor (LPF) and filamentous hemaglutinin (FHA) are isolated from the growth medium of the Bordatella pertussis organism and purified by selectively adsorbing the LPF and FHA on a selective adsorbing medium, such as filter aids or gel filtration media, at low ionic strength and subsequently removing the adsorbed LPF and FHA using an aqueous medium of high ionic strength, either simultaneously or sequentially. Prior to desorption of the LPF and FHA, the adsorbing medium may be contacted with an aqueous solution of an non-ionic detergent, which enables the LPF and FHA subsequently desorbed to be substantially free from contamination by lipopolysaccharides (LPS). The LPF and FHA may be further purified on hydroxyapatite. The LPF and FHA may be detoxified separately or together by contacting with a cross-linking agent, such as glutaraldehyde or formaldehyde, in the presence of an anti-aggregation agent. The resulting purified and detoxified LPF and FHA may be used to formulate a vaccine against pertussis.</p>
申请公布号 JPH0231689(A) 申请公布日期 1990.02.01
申请号 JP19890084926 申请日期 1989.04.05
申请人 KONNOOTO LAB LTD 发明人 RARII YUU ERU TAN;DEAAKU ARUKEMA;GEIRU JIYAKUSON;POO ESU WAA
分类号 C12P21/00;A61K38/36;A61K39/00;A61K39/10;A61P31/04;C07K1/16;C07K1/22;C07K14/005;C07K14/195;C07K14/235;C07K14/41;C07K16/00;C12R1/01 主分类号 C12P21/00
代理机构 代理人
主权项
地址